Newsfeeds - Spark Newswire

1 minute read

CytomX Therapeutics Announces Milestone Achievement In Probody T-Cell Engaging Bispecific Collaboration With Astellas

Today, 9:57 PM

-Achievement of clinical candidate is the first in the multi-target collaboration and triggers a $5 million milestone payment to CytomX- -CytomX-retained US co-commercialization and economic rights

CTMX

2 minute read

5 Most Expensive Health Care Stocks You Should Worry About

By Lisa Levin

Today, 9:57 PM

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

ATHE

3 minute read

Dow Jumps 700 Points; S&P 500 Rises Over 2%

By Lisa Levin

Today, 9:57 PM

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday.

AEHR

3 minute read

Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge

By Lisa Levin

Today, 9:57 PM

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.

AEHR

3 minute read

Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

Today, 9:57 PM

Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products that address larger markets.

ABVC

5 minute read

Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:57 PM

Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.

ACIU

3 minute read

Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 9:57 PM

Gainers Elevate Credit, Inc. (NYSE: ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million.

ARDX

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 9:57 PM

Gainers Ardelyx (NASDAQ:ARDX) shares moved upwards by 53.3% to $1.87 during Thursday’s regular session. Trading volume for Ardelyx’s…

AHPI

1 minute read

BMO Capital Downgrades CytomX Therapeutics to Market Perform, Lowers Price Target to $2.6

By Benzinga Newsdesk

Today, 9:57 PM

BMO Capital analyst Etzer Darout downgrades CytomX Therapeutics (NASDAQ:CTMX) from Outperform to Market Perform and lowers the price target from $3 to $2.6.

CTMX

16 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 9:57 PM

On Wednesday, 283 companies set new 52-week lows.

ACHL